Sei Investments Co. Sells 3,571 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Sei Investments Co. reduced its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 180,486 shares of the company’s stock after selling 3,571 shares during the period. Sei Investments Co.’s holdings in Acadia Healthcare were worth $7,156,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Nisa Investment Advisors LLC boosted its holdings in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after acquiring an additional 301 shares during the period. Pacer Advisors Inc. lifted its stake in Acadia Healthcare by 2.4% in the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company’s stock worth $549,000 after purchasing an additional 325 shares in the last quarter. Tidal Investments LLC boosted its holdings in Acadia Healthcare by 7.9% in the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock valued at $296,000 after purchasing an additional 340 shares during the period. Blue Trust Inc. increased its holdings in shares of Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after purchasing an additional 345 shares during the period. Finally, Coldstream Capital Management Inc. raised its position in shares of Acadia Healthcare by 7.5% in the third quarter. Coldstream Capital Management Inc. now owns 6,167 shares of the company’s stock worth $391,000 after buying an additional 430 shares in the last quarter.

Analysts Set New Price Targets

A number of equities analysts have weighed in on ACHC shares. KeyCorp decreased their target price on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Monday, March 3rd. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Royal Bank of Canada dropped their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Finally, Bank of America decreased their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $52.19.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $30.32 on Tuesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a fifty-two week low of $27.61 and a fifty-two week high of $82.41. The business has a 50 day moving average price of $36.87 and a 200-day moving average price of $44.50. The firm has a market cap of $2.82 billion, a PE ratio of 9.94, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.